Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.

ABSTRACT:

Background

Universal access to essential medicines and routine diagnostics is required to combat the growing burden of cardiovascular disease (CVD) and diabetes. Evaluating health systems and various access dimensions availability, affordability, accessibility, acceptability, and quality is crucial yet rarely performed, especially in low- and middle-income countries.

Objective

To evaluate health system capacity and barriers in accessing diagnostics and essential medicines for CVD and diabetes in Nepal.

Methods

We conducted a WHO/HAI nationally-representative survey in 45 health-facilities (public-sector: 11; private-sector: 34) in Nepal to collect availability and price data for 21 essential medicines for treating CVD and diabetes, during MayJuly 2017. Data for 13 rou

SUBMITTER: Sharma A 

PROVIDER: S-EPMC8139299 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature